Publications by authors named "Yvonne Saenger"

50Publications

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.

Transl Lung Cancer Res 2020 Aug;9(4):1074-1083

Molecular Oncology Laboratory, Fundación para la Investigación del Hospital General Universitario de Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr-19-445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481598PMC
August 2020

Oncolytic Viruses for the Treatment of Metastatic Melanoma.

Curr Treat Options Oncol 2020 03 19;21(4):26. Epub 2020 Mar 19.

Department of Medicine, Division of Hematology Oncology, Columbia University, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-020-0718-2DOI Listing
March 2020

Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.

Eur J Nucl Med Mol Imaging 2020 Sep 23;47(10):2301-2312. Epub 2020 Mar 23.

Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, 168th Street, New York, NY, 10039, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-020-04757-3DOI Listing
September 2020

Tissue-Resident Memory T Cells Mediate Immune Homeostasis in the Human Pancreas through the PD-1/PD-L1 Pathway.

Cell Rep 2019 12;29(12):3916-3932.e5

Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032, USA; Department of Surgery, Columbia University Medical Center, New York, NY 10032, USA; Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.11.056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939378PMC
December 2019

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma.

Am J Clin Dermatol 2020 Feb;21(1):1-11

Department of Medicine, Columbia University Irving Medical Center, 630 West 168th Street, P&S 9-428, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-019-00475-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994371PMC
February 2020

Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.

Eur Radiol 2020 Jan 23;30(1):558-570. Epub 2019 Aug 23.

Department of Radiology, New York Presbyterian Hospital, Columbia University Vagelos College of Physicians and Surgeons, New York City, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06347-wDOI Listing
January 2020

Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy.

Hematol Oncol Clin North Am 2019 04 17;33(2):291-299. Epub 2019 Jan 17.

Department of Medicine, Columbia University Irving Medical Center, 650 West 168th Street, Black Building 8-816, New York, NY 10032, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497069PMC
April 2019

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma.

Curr Oncol Rep 2018 11 13;20(12):100. Epub 2018 Nov 13.

Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-018-0749-z
Publisher Site
http://dx.doi.org/10.1007/s11912-018-0749-zDOI Listing
November 2018

The Role of Oncolytic Viruses in the Treatment of Melanoma.

Curr Oncol Rep 2018 08 25;20(10):80. Epub 2018 Aug 25.

Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-018-0729-3
Publisher Site
http://dx.doi.org/10.1007/s11912-018-0729-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450085PMC
August 2018

IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy.

Cell Syst 2018 07 27;7(1):92-103.e4. Epub 2018 Jun 27.

Department of Dermatology, Columbia University Medical Center, New York, NY, USA; Department of Genetics and Development, Columbia University Medical Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cels.2018.05.020DOI Listing
July 2018

Current and Emerging Therapies in Metastatic Pancreatic Cancer.

Clin Cancer Res 2017 Apr;23(7):1670-1678

Division of Medical Oncology, Columbia University Medical Center, and New York Presbyterian Hospital, Herbert Irving Pavilion, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2319DOI Listing
April 2017

Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers.

Semin Oncol 2016 Dec 27;43(6):638-646. Epub 2016 Oct 27.

Hematology/Oncology, New York-Presbyterian/Columbia University Medical Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.10.005DOI Listing
December 2016

Introducing cancer convergence.

Cancer Converg 2017 1;1(1). Epub 2017 Nov 1.

6Oregon State University, Corvallis, OR USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41236-017-0003-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876691PMC
November 2017

Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.

Cancer Immunol Res 2015 Mar 19;3(3):296-304. Epub 2015 Jan 19.

Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Medicine, Columbia University Medical Center, New York, New York. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690202PMC
March 2015

Blood mRNA expression profiling predicts survival in patients treated with tremelimumab.

Clin Cancer Res 2014 Jun 10;20(12):3310-8. Epub 2014 Apr 10.

Authors' Affiliations: Division of Hematology and Oncology, Tisch Cancer Institute, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York; Statistical Innovations, Belmont; Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Departments of Medicine, Dermatology and Translational Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and Gene News, Ontario, CanadaAuthors' Affiliations: Division of Hematology and Oncology, Tisch Cancer Institute, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York; Statistical Innovations, Belmont; Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Departments of Medicine, Dermatology and Translational Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and Gene News, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2906DOI Listing
June 2014

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.

J Am Acad Dermatol 2014 Jun 31;70(6):1036-44. Epub 2014 Mar 31.

Department of Dermatology, Mount Sinai School of Medicine, New York, New York; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.01.914DOI Listing
June 2014

A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.

Gastroenterology 2014 Jun 6;146(7):1784-94.e6. Epub 2014 Mar 6.

The Sidney Kimmel Comprehensive Cancer Center, the Skip Viragh Center for Clinical Pancreatic Cancer Research, and the Sol Goldman Pancreatic Cancer Center at Johns Hopkins, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.02.055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035450PMC
June 2014

Oncolytic virus therapy for cancer.

Oncolytic Virother 2013 23;2:31-46. Epub 2013 Sep 23.

Department of Immunology & Microbiology, Rush University Medical Center, Chicago IL, USA; Department of Surgery, Rush University Medical Center, Chicago IL, USA.

View Article

Download full-text PDF

Source
http://www.dovepress.com/oncolytic-virus-therapy-for-cancer-
Publisher Site
http://dx.doi.org/10.2147/OV.S38901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918352PMC
August 2016

Melanoma immunotherapy.

Mt Sinai J Med 2010 Nov-Dec;77(6):620-42

Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/msj.20215DOI Listing
June 2011

Herpes simplex virus oncolytic vaccine therapy in melanoma.

Expert Opin Biol Ther 2010 Jul;10(7):1145-53

The Mount Sinai School of Medicine, The Tisch Cancer Institute, Division of Hematology/Oncology, Department of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2010.495383DOI Listing
July 2010

Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.

Cancer Res 2008 Dec;68(23):9884-91

The Swim Across America Laboratory, Immunology Program, Department of Medicine, Memorial Sloan-Kettering Cancer Center, and Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-2233DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742375PMC
December 2008

The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.

Oncologist 2008 ;13 Suppl 4:2-9

Melanoma/Sarcoma Oncology Service and Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box #340, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.13-S4-2DOI Listing
January 2009

The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases.

Cancer Immun 2008 Jan 17;8. Epub 2008 Jan 17.

Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935787PMC
January 2008

Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation.

Proc Natl Acad Sci U S A 2007 Dec 11;104(51):20472-7. Epub 2007 Dec 11.

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0709878104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2154455PMC
December 2007

Current topics in melanoma.

Curr Opin Oncol 2007 Mar;19(2):116-20

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200703000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32801497c6DOI Listing
March 2007